|
KR20190090729A
|
|
A Novel Tofacitinib Salt, Preparation Methods thereof and Pharmaceutical Compositions Comprising thereof
|
|
KR101781352B1
|
|
Crystalline forms of novel varenicline salts, preparation methods thereof and pharmaceutical compositions comprising thereof
|
|
KR20180042565A
|
|
Tablet comprising Celecoxib
|
|
KR101715682B1
|
|
Novel intermediates for preparing saxagliptin, preparing methods thereof and preparing methods of saxagliptin using the same
|
|
KR20160148371A
|
|
Novel intermediates for preparing DPP-IV inhibitors, preparing method thereof and preparing method of DPP-IV inhibitors using the same
|
|
KR20160142578A
|
|
Method for preparing crystalline form I of Clopidogrel hydrogen sulfate
|
|
KR20130109609A
|
|
Process for the preparation of solifenacin or salt thereof and novel intermediates used in the process
|
|
KR20110089671A
|
|
Process for the preparation of valsartan and novel intermediates used in the process
|
|
KR20110081382A
|
|
Crystalline adefovir dipivoxil anhydrous, preparation method the same and pharmaceutical composition containing the same
|
|
KR20110081383A
|
|
Process for the preparation of lamivudine and novel intermediates used in the process
|
|
KR20080098964A
|
|
Pharmaceutical composition containing clopidogrel hydrogen sulfate and preparing method thereof
|
|
KR20080060420A
|
|
Method for preparing crystalline clopidogrel??bisulfate form i
|
|
KR100742134B1
|
|
Pharmaceutical composition comprising crystalline s-(+)-methyl-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4h)-yl)acetate.camsylate
|
|
KR20060012670A
|
|
2-amino-9-(2-substituted ethyl)purines and preparing methods thereof
|
|
KR20060109626A
|
|
Preparing methods for (-)-2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-acetic acid
|
|
KR20050020575A
|
|
PREPARING METHOD FOR CONTROLLED RELEASED TYPE TABLET TAMSULOSIN HCl AND THE TABLET THEREOF
|
|
KR20050049887A
|
|
Method for preparing risperidone and effective novel intermediate in the same
|
|
KR20050010092A
|
|
Preparing method for 2-Amino-9-(2-halogenoethyl)purine and Novel 2-Amino-6,8-dichloro-9-(2-hydroxyethyl)purine as an Intermediate
|
|
KR20040107812A
|
|
2-amino-9-(2-substituted ethyl)purines and preparing methods for 9-[4-acetoxy-3-(acetoxymethyl)but-1-yl]-2- aminopurine using the same
|
|
KR20040067214A
|
|
Preparing Method for (S)-1,4- dihydropyridine
|
